Selenium-Enriched Yeast Supplementation Studies

The rationale for taking a selenium-enriched yeast preparation: one or more of the selenium compounds in the preparation other than selenomethionine may be the selenium species that has specific effects against cancer. This is an area for further research.

Glass of beer made using brewer's yeast
Selenium-enriched yeast preparations use Saccharomyces cerevisiae, commonly known as as brewer’s yeast. The yeast is grown in a selenium-enriched medium in which the yeast absorbs the selenium. The finished preparation is pasteurized, causing the yeast cells to die. Selenium-enriched yeast preparations contain many organic selenium compounds in addition to selenomethionine.

This week, we focus on studies conducted with a selenium-enriched yeast preparation containing at least 20 different species of selenium in addition to selenomethionine [Bendahl & Gammelgaard 2004].

Randomized, double-blind, controlled clinical trials are the gold standard method for testing the safety, absorption, and efficacy of nutritional supplements and medical drugs. Below, we summarize some of the important clinical trials of nutritional interventions using selenium-enriched yeast. read more

Chronic Fatigue Syndrome and Impaired Selenium Transport

In a considerable number of chronic fatigue syndrome patients, researchers have observed the presence of autoantibodies to the selenium transporter Selenoprotein P. These autoantibodies disturb the normal transport of selenium to the tissues  in the body. They cause lower than normal levels of the antioxidant selenoenzyme glutathione peroxidase and lower than normal levels of deiodinase enzyme activity [Sun 2023].

Tired young woman at computer
Chronic fatigue syndrome is a complicated disorder that causes abnormal fatigue lasting six months or longer. Impaired selenium transport may be a factor underlying chronic fatigue syndrome.

Note: Autoantibodies are antibodies produced by the immune system and directed against the individual’s own proteins, in this case against selenoprotein P proteins. In an earlier study, researchers have identified autoantibodies to selenoprotein P in patients with Hashimoto’s thyroiditis, in which case the autoantibodies also impair selenium transport and selenoprotein expression [Sun 2021]. read more